David Cole to Combined Modality Therapy
This is a "connection" page, showing publications David Cole has written about Combined Modality Therapy.
Connection Strength
0.077
-
Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors. J Control Release. 2014 Mar 28; 178:79-85.
Score: 0.024
-
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8.
Score: 0.022
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.016
-
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
Score: 0.009
-
Combined surgery and radiotherapy for conservative management of soft tissue sarcomas. Recent Results Cancer Res. 1995; 138:47-55.
Score: 0.006